Related Experiment Video

Updated: Aug 6, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Medullary thyroid cancer

Y Nancy You1, Vipul Lakhani, Samuel A Wells

  • 1Department of Surgery, Mayo Clinic, Gonda 12, 200 First Street SW, Rochester, MN 55905, USA.

Surgical Oncology Clinics of North America
|August 3, 2006
PubMed

Insights

Early detection and surgical removal are key for managing medullary thyroid carcinoma (MTC). Screening methods enable prophylactic surgery for hereditary MTC, while new therapies offer hope for advanced cases.

Area of Science:

  • Oncology
  • Genetics
  • Surgical Management

Background:

  • Medullary thyroid carcinoma (MTC) management focuses on early disease detection and complete surgical resection.
  • Hereditary MTC risk can be mitigated through tumor marker and genetic screening, facilitating prophylactic surgery.
  • While complete resection is crucial for cure, reoperation for recurrent MTC offers benefits only to select patients.

Purpose of the Study:

  • To outline the current strategies for managing medullary thyroid carcinoma.
  • To highlight the importance of early detection and surgical intervention.
  • To discuss emerging therapeutic options for advanced or metastatic MTC.

Main Methods:

  • Review of current clinical practices in MTC management.
  • Analysis of screening protocols including biochemical and genetic testing.
  • Evaluation of surgical outcomes and therapeutic advancements.

Main Results:

  • Early-stage detection and surgical removal are paramount for MTC patient outcomes.
  • Screening enables timely prophylactic surgery in individuals with hereditary MTC.
  • Targeted therapies for RET-activated pathways show promise for advanced and metastatic MTC.

Conclusions:

  • Effective MTC management relies on early diagnosis and complete surgical resection.
  • Genetic screening plays a vital role in preventing hereditary MTC through prophylactic surgery.
  • Advancements in targeted therapies provide new hope for patients with advanced or metastatic medullary thyroid carcinoma.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
The Thyroid Gland01:23

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...